Present Status Of Aureomycin Therapy

Article1 July 1949PRESENT STATUS OF AUREOMYCIN THERAPYMAXWELL FINLAND, M.D., F.A.C.P., HARVEY SHIELDS COLLINS, M.D., THOMAS M. GOCKE, M.D., E. BUIST WELLS, M.D.MAXWELL FINLAND, M.D., F.A.C.P.Search for more papers by this author, HARVEY SHIELDS COLLINS, M.D.Search for more papers by this author, THOMAS M. GOCKE, M.D.Search for more papers by this author, E. BUIST WELLS, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-31-1-39 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAureomycin is the most recent antibiotic to be accepted into the group of antimicrobial agents that are highly effective in the therapy of human infections. The activity of this antibiotic seems to extend over a wider range of infectious agents than that of any of its predecessors. It is effective when given by mouth and has thus far been found to be essentially free of serious untoward effects. The exact field of usefulness of aureomycin, however, still remains to be defined and it will be necessary to accumulate a considerably greater body of well controlled clinical data than are as...Bibliography1. DUGGAR BM: Aureomycin, a product of the continuing search for new antibiotics, Ann. New York Acad. Sci., 1948, li, 177-181. CrossrefGoogle Scholar2. BROSCHARD RW: Aureomycin, a new antibiotic, Science, 1949, cix, 199-200. CrossrefGoogle Scholar3. HARNED BK: The pharmacology of duomycin, Ann. New York Acad. Sci., 1948, li, 182-210. CrossrefGoogle Scholar4. BARTZ QR: Isolation and characterization of Chloromycetin, Jr. Biol. Chem., 1948, clxxii, 445-450. CrossrefGoogle Scholar5. SMITH RM: Chloromycetin: biological studies, Jr. Bact., 1948, lv, 425-448. CrossrefGoogle Scholar6. PAINECOLLINSFINLAND TFHSM: Bacteriologic studies on aureomycin, Jr. Bact., 1948, lvi, 489-497. CrossrefGoogle Scholar7. CHANDLERBLISS CAEA: In vitro studies with aureomycin, Ann. New York Acad. Sci., 1948, li, 221-227. CrossrefGoogle Scholar8. BLISSCHANDLER EACA: In vitro studies of aureomycin, a new antibiotic agent, Proc. Soc. Exper. Biol. and Med., 1948, lxix, 467-472. CrossrefGoogle Scholar9. MEADSHASLAMSTEVENS MNMKM: In vitro observations on the antibacterial activity of aureomycin, North Carolina Med. Jr., 1948, ix, 568-574. Google Scholar10. BRYERSCHOENBACHBLISSCHANDLER MSEBEACA: Treatment of experimental infections with aureomycin, Ann. New York Acad. Sci., 1948, li, 254-266. CrossrefGoogle Scholar11. PRICERANDALLWELCH CWWAH: Bacteriological studies of aureomycin, Ann. New York Acad. Sci., 1948, li, 211-217. CrossrefGoogle Scholar12. HEILMAN FO: Aureomycin in the treatment of experimental relapsing fever and Leptospirosis icterohemorrhagica (Weil's disease), Proc. Staff Meet. Mayo Clin., 1948, xxiii, 569-573. Google Scholar13. COLLINSWELLSPAINEFINLAND HSEBTFM: Urinary excretion of aureomycin. Preliminary report, Proc. Soc. Exper. Biol. and Med., 1948, lxix, 174-175. CrossrefGoogle Scholar14. DOWLINGLEPPERSWEETBRICKHOUSE HFMHLKRL: Studies on serum concentrations in humans and preliminary observations on the treatment of human infections with aureomycin, Ann. New York Acad. Sci., 1948, li, 241-245. CrossrefGoogle Scholar15. SCHOENBACHBRYERLONG EBMSPH: The pharmacology and clinical trial of aureomycin: A preliminary report, Ann. New York Acad. Sci., 1948, li, 267-279. CrossrefGoogle Scholar16. BRAINERDBRUYNMEIKLEJOHNSCAPARONE HDHBGM: Assay of aureomycin in body fluids: Observations on individuals receiving aureomycin, Proc. Soc. Exper. Biol. and Med., 1949, lxx, 318-321. CrossrefGoogle Scholar17. MEADS M: Personal communication. Google Scholar17a. HERRELLHEILMAN WEFR: Aureomycin: Studies on absorption, diffusion and excretion, Proc. Staff Meet. Mayo Clinic, 1949, xxiv, 157-166. Google Scholar18. PAINECOLLINSFINLAND TFHSM: Laboratory studies with aureomycin, Ann. New York Acad. Sci., 1948, li, 228-230. CrossrefGoogle Scholar19. WONGCOX SCHR: Action of aureomycin against experimental rickettsial and viral infections, Ann. New York Acad. Sci., 1948, li, 290-305. CrossrefGoogle Scholar20. ANIGSTEINWHITNEYBENINSON LDMJ: Aureomycin—a new antibiotic with antirickettsial properties: Its effect on experimental spotted fever and epidemic typhus, Ann. New York Acad. Sci., 1948, li, 306-317. CrossrefGoogle Scholar21. LITTLE PA: Use of aureomycin on some experimental infections in animals, Ann. New York Acad. Sci., 1948, li, 246-253. CrossrefGoogle Scholar22. SPINKBRAUDECASTENEDAGOYTIA WWAIMRRS: Aureomycin therapy in human brucellosis due to Brucella melitensis , Jr. Am. Med. Assoc., 1948, cxxxviii, 1145-1148. CrossrefGoogle Scholar23. COOKE C: Rocky Mountain spotted fever treated with aureomycin, Jr. Am. Med. Assoc., 1948, cxxxviii, 885. CrossrefGoogle Scholar24. ROSSSCHOENBACHBURKEBRYERRICEWASHINGTON SEBFGMSECJA: Aureomycin therapy of Rocky Mountain spotted fever, Jr. Am. Med. Assoc., 1948, cxxxviii, 1213-1216. CrossrefGoogle Scholar25. HARRELLMEADSSTEVENS GTMK: "Aureomycin" a new orally effective antibiotic. Clinical trial in Rocky Mountain spotted fever, results of susceptibility tests and blood assays using a turbidimetric method, South. Med. Jr., 1949, xlii, 4-13. CrossrefGoogle Scholar26. HILL EL: Discussion of paper by Harrell et al.25 Google Scholar27. KNIGHTRUIZ-SANCHEZRUIZ-SANCHEZMCDERMOTT VFAW: Aureomycin in typhus and brucellosis, Am. Jr. Med., 1949, vi, 407-416. CrossrefGoogle Scholar28. LENNETTEMEIKLEJOHNTHELEN EHGHM: Treatment of Q fever in man with aureomycin, Ann. New York Acad. Sci., 1948 li, 331-342. CrossrefGoogle Scholar29. SCHOENBACH EB: Aureomycin therapy of recrudescent epidemic typhus (Brill's disease), Jr. Am. Med. Assoc., 1949, cxxxix, 450-452. CrossrefGoogle Scholar30. WOODWARD TE: Chloromycetin and aureomycin: Therapeutic results, Ann. Int. Med., 1949, xxxi, 53-82. Google Scholar31. WRIGHTSANDERSLOGANPRIGOTHILL LTMMAALM: Aureomycin: a new antibiotic with viricidal properties. 1. A preliminary report on successful treatment in 25 cases of lymphogranuloma venereum, Jr. Am. Med. Assoc., 1948, cxxxviii, 408-412. CrossrefGoogle Scholar32. WRIGHTSANDERSLOGANPRIGOTHILL LTMMAALM: The treatment of lymphogranuloma venereum and granuloma inguinale in humans with aureomycin, Ann. New York Acad. Sci., 1948, li, 318-330. CrossrefGoogle Scholar33. KNEELANDROSEGIBSON YHMCD: Aureomycin in the treatment of primary atypical pneumonia, Am. Jr. Med., 1949, vi, 41-50. CrossrefGoogle Scholar34. SCHOENBACHBRYER EBMS: Treatment of primary atypical nonbacterial pneumonia with aureomycin, Jr. Am. Med. Assoc., 1949, cxxxix, 275-280. CrossrefGoogle Scholar35. FINLANDCOLLINSWELLS MHSEB: Aureomycin in treatment of primary atypical pneumonia, New England Jr. Med., 1949, ccxl, 241-246. CrossrefGoogle Scholar36. Unpublished observations. Google Scholar37. COLLINSPAINEFINLAND HSTFM: Aureomycin in treatment of pneumococcal pneumonia and meningococcemia, Proc. Soc. Exper. Biol. and Med., 1948, lxix, 263-265. CrossrefGoogle Scholar38. SHWACHMANFARBER HS: Personal communication. Google Scholar39. COLLINSPAINEFINLAND HSTFM: Clinical studies with aureomycin, Ann. New York Acad. Sci., 1948, li, 231-240. CrossrefGoogle Scholar40. COLLINSPAINEWELLSFINLAND HSTFEBM: Aureomycin—a new antibiotic. Evaluation of its effects in typhoid fever, severe salmonella infections and in a case of colon bacillus bacteremia, Ann. Int. Med., 1948, xxix, 1077-1092. Google Scholar41. MCDERMOTTKNIGHTRUIZ-SANCHEZ WVF: The antimicrobial therapy of typhoid fever. To be published. Google Scholar42. WOODWARDSMADELLEYGREENMANKIKAR TEJEHLRDS: Preliminary report on the beneficial effect of Chloromycetin in the treatment of typhoid fever, Ann. Int. Med., 1948, xxix, 131-134. Google Scholar43. BRYERSCHOENBACHCHANDLERBLISSLONG MSEBCAEAPH: Aureomycin. Experimental and clinical investigations, Jr. Am. Med. Assoc., 1948, cxxxviii, 117-119. CrossrefGoogle Scholar44. FINLANDCOLLINSPAINE MHSTF: Aureomycin, a new antibiotic. Results of laboratory studies and of clinical use in 100 cases of bacterial infections, Jr. Am. Med. Assoc., 1948, cxxxviii, 946-949. CrossrefGoogle Scholar45. COLLINSFINLAND HSM: Aureomycin treatment of urinary tract infections, Surg., Gynec. and Obst., in press. Google Scholar46. SPINK WW: Diagnosis and treatment of brucellosis (undulant fever), Veterans Administration Tech. Bull. TB 10-49, Washington, D. C., Feb. 28, 1949. Google Scholar47. WRIGHT LT: Treatment of acute peritonitis with aureomycin: A preliminary report of 49 cases, in press. Google Scholar48. RUTENBERGSCHWEINBERGFINE AMFBJ: To be published. Google Scholar49. BRALEYSANDERS AEM: Aureomycin in ocular infections. A preliminary report, Jr. Am. Med. Assoc., 1948, cxxxviii, 426-427. CrossrefGoogle Scholar50. BRALEYSANDERS AEM: Aureomycin in ocular infections. A study of its spectrum, Ann. New York Acad. Sci., 1948, li, 280-289. CrossrefGoogle Scholar51. COLLINSTROUSDALEKAISERREGANFINLAND HSHTFFCM: Aureomycin treatment of acute gonorrhea in males, Am. Jr. Syph., Gonor. and Ven. Dis., 1949, xxxiii, 263-269. Google Scholar52. O'LEARYKIERLANDHERRELL PARRWE: The oral administration of aureomycin (Duomycin) and its effect on Treponema pallidum in man, Proc. Staff Meet. Mayo Clin., 1948, xxiii, 574-578. Google Scholar53. WOODWARDRABYEPPESHOLBROOKHIGHTOWER TEWTWWAJA: Aureomycin in treatment of experimental and human tularemia, Jr. Am. Med. Assoc., 1949, cxxxix, 830-832. CrossrefGoogle Scholar54. MEIKLEJOHNSHRAGG GRI: Aureomycin in primary atypical pneumonia. A controlled evaluation, Jr. Am. Med. Assoc., 1949, cxl, 391-396. CrossrefGoogle Scholar55. RUTENBERGSCHWEINBERG AMFB: Aureomycin in urinary infections due to gram-negative organisms, Proc. Soc. Exper. Biol. and Med., 1949, lxx, 464-467. CrossrefGoogle Scholar56. IRGANGALEXANDER SER: Treatment of early syphilis with aureomycin. A preliminary report, Harlem Hosp. Bull., 1948, i, 91-98. Google Scholar57. MCVAYLAIRDSPRUNT LVRLDH: A preliminary report of the successful treatment of amebiasis with aureomycin, Science, cix, 590-591. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Presented at the Thirtieth Annual Session of the American College of Physicians, New York, March 30, 1949.From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital and the Department of Medicine, Harvard Medical School, Boston.Aided by a Grant from the United States Public Health Service.†Milton Fellow, Harvard Medical School.‡Research Fellow in Virus Diseases, National Research Council. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDie AntibioticaAntibiotikaThe Mode of Action of Aureomycin in the Guinea-pigDas Q-FieberExperimenteller Beitrag zur Resistenzsteigerung bakterieller Erreger gegen Streptomycin und AureomycinAureomycin in Urinary Tract InfectionsAureomycin in the treatment of beta hemolytic streptococcal infectionsSome recent advances and current problems in the field of rickettsial diseasesAureomycin in pediatrics: A reviewEpidemic Herpes Zoster OphthalmicusDiscussion on the Present Position of the Newer AntibioticsAureomycinTHE ANTIBIOTICS IN UROLOGY1Antibiotics in Non-Tuberculous Pulmonary Diseases 1 July 1949Volume 31, Issue 1Page: 39-52KeywordsAntibioticsAntimicrobialsHospital medicineMedical servicesMouthResearch laboratories ePublished: 1 December 2008 Issue Published: 1 July 1949 PDF downloadLoading ...